Peak Concentrations of Ustekinumab After Intravenous Induction Therapy Identify Patients With Crohn’s Disease Likely to Achieve Endoscopic and Biochemical Remission
Jurij Hanžel, Jurij Zdovc, Tina Kurent, Nejc Sever, Katarina Javornik, Katja Tuta, Matic Koželj, Nataša Smrekar, Gregor Novak, Borut Štabuc, Erwin Dreesen, Debby Thomas, Tomaž Vovk, Iztok Grabnar, David Drobne
Topics & Concepts
MedicineUstekinumabCalprotectinGastroenterologyInternal medicineCrohn's diseaseArea under the curveProspective cohort studyDiseaseInflammatory bowel diseaseInfliximabInflammatory Bowel DiseaseAutoimmune and Inflammatory DisordersRheumatoid Arthritis Research and Therapies